Additionally, it was active at low nanomolar levels and was recently reported as effective against NAFLD in mice by activating the NRF2 pathway and reducing the inflammatory response [49]. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.